$10.00 Add to Cart

Afucoâ„¢ Anti-Human BST2 ADCC Theraputic Antibody (XmAb 5592), ADCC Enhanced

Afucoâ„¢ Anti-Human BST2 ADCC Theraputic Antibody (XmAb 5592), ADCC Enhanced

More than 10 available

Details

Shipping: US-Mainland: free (more destinations)

Condition: Brand new

*The store has not been updated recently. You may want to contact the merchant to confirm the availability of the product.

    
Anti-BST2 ADCC Enhanced Antibody (XmAb 5592) is an ADCC enhanced antibody produced by our Afuco™ platform. XmAb5592, a humanized anti-HM1. 24 mAb with Fc-domain engineered to significantly enhance FcγR binding and associated immune effector functions. The clinical development of XmAb5592, both as a monotherapy and in combination with lenalidomide, to improve patient outcome of multiple myeloma (MM).

https://www.creativebiolabs.net/Anti-BST2-ADCC-Enhanced-Antibody-XmAb-5592-20378.htm